# Febuxostat

NDC: 0904-7484
Generic name: Febuxostat
Labeler / Manufacturer: Major Pharmaceuticals
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20240522
Marketing ended: 20260731
FDA application: ANDA210461

## Active ingredients

- FEBUXOSTAT: 40 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0904-7484"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0904-7484
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=164feabd-f722-445b-b81a-d975b3db5f53